Qin Xu

FDA investigator

Appears on 4 documents from 2015 to 2019, mostly at sites in Maryland. Most often cites production record review (21 CFR 211.192).

4
Documents on file
6.0
Observations per 483
2015
First seen
2019
Most recent

What they cite most

From 24 observations

Activity by year

2015: 2, 2016: 1, 2019: 1

Where

Maryland 3 · India 1

Is Qin Xu coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 C-Care LLCSep 16, 2019 · Linthicum Heights, Maryland
483 Eisai, IncJul 22, 2016 · Baltimore, Maryland
483 Cape Apothecary Inc.Oct 7, 2015 · Annapolis, Maryland
483 Alkem Laboratories LimitedJul 31, 2015 · Solan, India

About this profile

What does Qin Xu inspect?

Qin Xu appears on 4 documents on file covering 4 sites, mostly in Maryland.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.113 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Qin Xu is dated Sep 16, 2019.